AI Summary

Researchers at UC Davis’s National Center for Interventional Biophotonic Technologies completed the first‑in‑human trial of a flexible, catheter‑based imaging device designed to navigate artery walls and capture real‑time details of plaque buildup. The dual‑imaging catheter aims to improve detection of atherosclerosis and guide personalized treatment of cardiovascular disease. Founding director Laura Marcu highlighted the test as a major step toward advancing heart health and better understanding disease progression. The study marks the initial human evaluation of the technology developed in NCIBT labs.

AI summaries can be wrong sometimes—always verify important details using the source article.